Ergoteles LLC Coherus Bio Sciences, Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.79 - $8.3 $62,914 - $137,780	16,600 New	16,600 $70,000
Q2 2022 Aug 12, 2022	SELL	$5.86 - $13.23 $261,965 - $591,433	-44,704 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$10.92 - $16.41 $51,182 - $76,913	4,687 Added 11.71%	44,704 $577,000
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $417,652 - $501,658	26,417 Added 194.24%	40,017 $639,000
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $172,448 - $241,944	13,600 New	13,600 $219,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.